Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership237,580 shares
Latest Disclosed Value $ 5,369,308
Invesco Ltd. reports 2.90% decrease in ownership of PCRX / Pacira BioSciences, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 237,580 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $5,369,308 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 244,679 shares of Pacira BioSciences, Inc.. This represents a change in shares of -2.90% during the quarter. The current value of the position is $5,385,939 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 237,580 -7,099 -2.90 5,369 -15.21 0.0008
2026-02-19 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 244,679 -272,745 -52.71 6,332 -52.51 0.0010
2025-11-13 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 517,424 38,025 7.93 13,334 16.38 0.0021
2025-08-13 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 479,399 -145,466 -23.28 11,458 -26.21 0.0019
2025-05-12 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 624,865 384,419 159.88 15,528 242.76 0.0029
2025-02-13 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 240,446 -683,699 -73.98 4,530 -67.43 0.0008
2024-11-12 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 924,145 375,538 68.45 13,908 -11.39 0.0027
2024-08-13 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 548,607 -2,052 -0.37 15,696 -2.45 0.0033
2024-05-14 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 550,659 71,065 14.82 16,090 -0.56 0.0035
2024-02-13 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 479,594 -435,113 -47.57 16,182 -42.34 0.0039
2023-11-13 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 914,707 -470,177 -33.95 28,063 -49.43 0.0076
2023-08-11 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 1,384,884 -13,602 -0.97 55,492 -2.77 0.0145
2023-05-12 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 1,398,486 37,853 2.78 57,072 8.64 0.0159
2023-02-13 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 1,360,633 217,664 19.04 52,534 -13.59 0.0154
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 1,142,969 54,228 4.98 60,795 -4.22 0.0196
2022-08-15 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 1,088,741 716,018 192.10 63,474 123.14 0.0192
2022-05-16 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 372,723 -98,643 -20.93 28,446 0.30 0.0073
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 471,366 -68,138 -12.63 28,362 -6.12 0.0068
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 539,504 85,413 18.81 30,212 9.65 0.0077
2021-08-17 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 454,091 -100,599 -18.14 27,554 -29.13 0.0068
2021-05-17 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 554,690 -49,865 -8.25 38,878 7.47 0.0104
2021-02-16 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 604,555 -481 -0.08 36,177 -0.54 0.0105
2020-11-16 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 605,036 -67,008 -9.97 36,374 3.15 0.0123
2020-08-14 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 672,044 223,137 49.71 35,262 134.27 0.0126
2020-05-15 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 448,907 -161,445 -26.45 15,052 -45.56 0.0063
2020-02-14 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 610,352 380,422 165.45 27,649 215.84 0.0086
2019-11-14 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 229,930 -80,849 -26.01 8,754 -35.23 0.0023
2019-08-14 2019-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 310,779 -86,362 -21.75 13,516 -10.58 0.0035
2019-08-14 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 310,779 -353,321 13,516
2019-05-15 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 397,141 24,225 6.50 15,116 -5.78 0.0051
2019-02-14 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 372,916 -49,152 -11.65 16,044 -22.66 0.0061
2018-11-14 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 422,068 391,991 1,303.29 20,745 2,051.97 0.0065
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 30,077 -130,775 -81.30 964 -80.76 0.0003
2018-05-15 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 160,852 -490,792 -75.32 5,011 -83.15 0.0019
2018-02-14 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 651,644 -14,532 -2.18 29,747 18.92 0.0107
2017-11-14 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 666,176 -5,055 -0.75 25,015 -21.87 0.0092
2017-08-14 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 671,231 -9,672 -1.42 32,017 3.11 0.0100
2017-05-15 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 680,903 7,166 1.06 31,050 42.69 0.0102
2017-02-14 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 673,737 133,332 24.67 21,761 17.68 0.0073
2016-11-14 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 540,405 1,549 0.29 18,492 1.74 0.0064
2016-08-15 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 538,856 -274,402 -33.74 18,176 -57.82 0.0067
2016-05-16 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 813,258 -67,916 -7.71 43,087 -36.32 0.0175
2016-02-16 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 881,174 -32,105 -3.52 67,665 80.27 0.0270
2015-11-16 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 913,279 -465,807 -33.78 37,536 -61.51 0.0159
2015-08-14 2015-06-30 13F PACIRA PHARMACEUTICALS COMMON 695127100 1,379,086 208,499 17.81 97,529 -6.23 0.0383
2015-05-15 2015-03-31 13F PACIRA PHARMACEUTICALS COMMON 695127100 1,170,587 -33,299 -2.77 104,007 -2.56 0.0402
2015-02-13 2014-12-31 13F PACIRA PHARMACEUTICALS COMMON 695127100 1,203,886 466,224 63.20 106,737 49.29 0.0412
2014-11-14 2014-09-30 13F PACIRA PHARMACEUTICALS COMMON 695127100 737,662 110,248 17.57 71,495 24.05 0.0285
2014-08-14 2014-06-30 13F PACIRA PHARMACEUTICALS COMMON 695127100 627,414 500,092 392.78 57,635 546.78 0.0227
2014-05-15 2014-03-31 13F PACIRA PHARMACEUTICALS COMMON 695127100 127,322 76,353 149.80 8,911 204.13 0.0036
2014-02-13 2013-12-31 13F PACIRA PHARMACEUTICALS COMMON 695127100 50,969 -9,945 -16.33 2,930 0.07 0.0012
2013-11-13 2013-09-30 13F PACIRA PHARMACEUTICALS COMMON 695127100 60,914 43,450 248.80 2,928 478.66 0.0013
2013-08-14 2013-06-30 13F PACIRA PHARMACEUTICALS COMMON 695127100 17,464 17,464 506 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.